1. Activation of Latent Human Immunodeficiency Virus by the Histone Deacetylase Inhibitor Panobinostat: A Pilot Study to Assess Effects on the Central Nervous System. (9th March 2015) Authors: Rasmussen, Thomas A.; Tolstrup, Martin; Møller, Holger Jon; Brinkmann, Christel R.; Olesen, Rikke; Erikstrup, Christian; Laursen, Alex L.; Østergaard, Lars; Søgaard, Ole S. Journal: Open forum infectious diseases Issue: Volume 2:Number 1(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Administration of Panobinostat Is Associated with Increased IL-17A mRNA in the Intestinal Epithelium of HIV-1 Patients. (1st December 2015) Authors: Bjerg Christensen, Ane; Dige, Anders; Vad-Nielsen, Johan; Brinkmann, Christel R.; Bendix, Mia; Østergaard, Lars; Tolstrup, Martin; Søgaard, Ole S.; Rasmussen, Thomas A.; Randel Nyengaard, Jens; Agnholt, Jørgen; Denton, Paul W. Other Names: Chen Kong Academic Editor. Journal: Mediators of inflammation Issue: Volume 2015(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Beyond antiretroviral therapy: early interventions to control HIV-1 infection. (31st July 2017) Authors: Gunst, Jesper D.; Tolstrup, Martin; Søgaard, Ole S. Journal: AIDS Issue: Volume 31:Number 12(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Camostat mesylate against SARS‐CoV‐2 and COVID‐19—Rationale, dosing and safety. Issue 2 (22nd November 2020) Authors: Breining, Peter; Frølund, Anne Lier; Højen, Jesper Falkesgaard; Gunst, Jesper Damsgaard; Staerke, Nina B.; Saedder, Eva; Cases‐Thomas, Manuel; Little, Paul; Nielsen, Lars Peter; Søgaard, Ole S.; Kjolby, Mads Journal: Basic & clinical pharmacology & toxicology Issue: Volume 128:Issue 2(2021) Page Start: 204 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Candidate host epigenetic marks predictive for HIV reservoir size, responsiveness to latency reversal, and viral rebound. (15th November 2021) Authors: Corley, Michael J.; Pang, Alina P.S.; Rasmussen, Thomas A.; Tolstrup, Martin; Søgaard, Ole S.; Ndhlovu, Lishomwa C. Journal: AIDS Issue: Volume 35:Number 14(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Cellular immunogenicity of human papillomavirus vaccines Cervarix and Gardasil in adults with HIV infection. Issue 4 (3rd April 2018) Authors: Zurek Munk-Madsen, Maria; Toft, Lars; Kube, Tina; Richter, Rolf; Ostergaard, Lars; Søgaard, Ole S.; Tolstrup, Martin; Kaufmann, Andreas M. Journal: Human vaccines & immunotherapeutics Issue: Volume 14:Issue 4(2018) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characterization of the HIV-1 transcription profile after romidepsin administration in ART-suppressed individuals. (1st March 2019) Authors: Moron-Lopez, Sara; Kim, Peggy; Søgaard, Ole S.; Tolstrup, Martin; Wong, Joseph K.; Yukl, Steven A. Journal: AIDS Issue: Volume 33:Number 3(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Differences in antiretroviral regimens do not impact safety or level of latency reversal in persons receiving romidepsin. (31st July 2018) Authors: Jørgensen, Sofie; Leth, Steffen; Sommerfelt, Maja; Østergaard, Lars; Tolstrup, Martin; Søgaard, Ole S. Journal: AIDS Issue: Volume 32:Number 12(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Editorial: Immune-mediated control of HIV. Issue 5 (September 2021) Authors: Bar, Katharine J.; Søgaard, Ole S. Journal: Current opinion in HIV & AIDS Issue: Volume 16:Issue 5(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy of the TMPRSS2 inhibitor camostat mesilate in patients hospitalized with Covid-19-a double-blind randomized controlled trial. (May 2021) Authors: Gunst, Jesper D.; Staerke, Nina B.; Pahus, Marie H.; Kristensen, Lena H.; Bodilsen, Jacob; Lohse, Nicolai; Dalgaard, Lars S.; Brønnum, Dorthe; Fröbert, Ole; Hønge, Bo; Johansen, Isik S.; Monrad, Ida; Erikstrup, Christian; Rosendal, Regitze; Vilstrup, Emil; Mariager, Theis; Bove, Dorthe G.; Offers... Journal: EClinicalMedicine Issue: Volume 35(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗